biosynthetic gene clusters – Page 2

Draft genome of Conoideocrella luteorostrata ARSEF 14590 (Clavicipitaceae), an entomopathogenic fungus with a wealth of biosynthetic and biocontrol potential

mycolabadmin

Scientists have sequenced the complete genome of a fungus that naturally kills elongate hemlock scale insects, pests that damage Christmas trees. The fungus contains genes for producing cephalosporin, a well-known antibiotic, and other bioactive compounds. This discovery opens new possibilities for using this fungus as a natural pest control method and potentially developing new medicines from its biological compounds.

Penicillium psychrofluorescens sp. nov., a naturally autofluorescent Antarctic fungus

mycolabadmin

Scientists discovered a new cold-loving fungus in Antarctic soil that glows remarkably bright under ultraviolet light. This fungus, named Penicillium psychrofluorescens, produces its own fluorescent chemicals and contains many genes for making novel medicinal compounds. Its unique characteristics suggest it could be valuable for developing new medicines and biotechnological applications.

Exploring the Siderophore Portfolio for Mass Spectrometry-Based Diagnosis of Scedosporiosis and Lomentosporiosis

mycolabadmin

Two dangerous opportunistic fungi that cause serious infections in vulnerable patients produce distinct chemical compounds called siderophores to help them acquire iron from their hosts. Researchers used advanced mass spectrometry techniques to detect and measure these compounds, finding that one fungus produces significantly more of these iron-scavenging molecules, which may explain why it causes more severe infections. These siderophores could potentially be used as diagnostic markers in medical laboratories to quickly identify these infections in patient samples.

Gapless near Telomer-to-Telomer Assembly of Neurospora intermedia, Aspergillus oryzae, and Trichoderma asperellum from Nanopore Simplex Reads

mycolabadmin

Scientists developed an automated computer workflow that can assemble complete fungal genomes using data from a single type of DNA sequencer. They tested this method on three industrially important fungi and successfully created high-quality, gap-free genome maps for all three. This breakthrough means researchers can now generate high-quality fungal genome sequences faster and more cheaply than before, which will help improve our understanding of these organisms.

Comparative genome analysis of patulin-producing Penicillium paneum OM1 isolated from pears

mycolabadmin

Researchers sequenced the complete genome of a mold called Penicillium paneum that produces a toxic substance called patulin, which contaminates apples and pears. They found all 15 genes responsible for making patulin and discovered the mold has similar genetic patterns to other patulin-producing fungi. This information could help scientists develop better ways to prevent patulin contamination on fruit crops and improve food safety.

Integrated Transcriptomics and Metabolomics Provide Insight into Degeneration-Related Molecular Mechanisms of Morchella importuna During Repeated Subculturing

mycolabadmin

Morel mushrooms are prized edible fungi that unfortunately degrade when repeatedly cultured in the laboratory, becoming slower-growing and less productive. Researchers used advanced genetic and chemical analysis to discover that degeneration occurs when the mushroom stops producing flavonoids, natural antioxidants that protect cells from damage. A specific gene called NR-PKS is responsible for making these protective flavonoids, and it shuts down in degraded strains. The study suggests that preservation methods using cold storage or adding antioxidants could help maintain healthy, productive morel cultures.

Population structure in a fungal human pathogen is potentially linked to pathogenicity

mycolabadmin

Researchers studied 300 strains of Aspergillus flavus, a fungus that causes serious infections in people and damages crops. They found that strains causing human infections are not randomly distributed but instead belong to specific genetic groups, particularly a newly identified group called population D. This discovery suggests that certain genetic traits make some strains more likely to infect humans, providing insights that could lead to better treatments and prevention strategies.

Draft Genome Sequence of the Coprinoid Mushroom Coprinopsis strossmayeri

mycolabadmin

Scientists sequenced the complete genetic blueprint of Coprinopsis strossmayeri, a mushroom that lives in dung. By analyzing its genome, they discovered the mushroom produces multiple types of chemical compounds with antimicrobial properties that could be useful for developing new medicines. The research highlights how fungi living in competitive environments like dung have evolved to produce substances that could benefit human health through pharmaceutical applications.

Strategy of employing plug-and-play vectors and LC–MS screening to facilitate the discovery of natural products using Aspergillus oryzae

mycolabadmin

Researchers developed new tools to make it faster and easier to discover useful compounds from fungi. They created improved genetic vectors that allow scientists to insert multiple genes into Aspergillus oryzae more conveniently, and developed a quick screening method using mass spectrometry to identify successful transformants directly on culture plates. This approach saves about 10 days compared to traditional methods, significantly accelerating the discovery of new natural products with potential medical and agricultural applications.

mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million

mycolabadmin

Scientists have discovered about 30,000 fungal compounds with useful properties, from life-saving antibiotics like penicillin to cholesterol-lowering drugs. However, new research suggests that fungi actually produce somewhere between 1.4 million and 4.3 million different chemical compounds, meaning we’ve only discovered about 1-2% of what’s out there. By studying the genomes of fungi, researchers estimate that for every fungal medicine we know about, there could be 50-100 more waiting to be discovered, representing an enormous opportunity for developing new drugs and therapies.

Research Keyword: biosynthetic gene clusters